The FDA just approved a breakthrough drug for metastatic pancreatic cancer, which is notoriously hard to treat. In clinical trials, the new pill roughly doubled how long patients survived.
Copyright 2026 NPR
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C.
